Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 112, 104920
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid DerivativesMolecules, 2016
- Recent advances bioactive 1,2,4-triazole-3-thionesEuropean Journal of Medicinal Chemistry, 2015
- Molecular mechanisms of antibiotic resistanceNature Reviews Microbiology, 2014
- Structure-Based Discovery of Substituted 4,5′-Bithiazoles as Novel DNA Gyrase InhibitorsJournal of Medicinal Chemistry, 2012
- Exploiting bacterial DNA gyrase as a drug target: current state and perspectivesApplied Microbiology and Biotechnology, 2011
- Synthesis of 1,2,4-triazole-3-thiols and their S-substituted derivativesRussian Journal of Organic Chemistry, 2010
- Antimalarials from natureBioorganic & Medicinal Chemistry, 2009
- Oxadiazole mannich bases: Synthesis and antimycobacterial activityBioorganic & Medicinal Chemistry Letters, 2007
- Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsAntiviral Research, 2006
- Antifungal properties of new series of quinoline derivativesBioorganic & Medicinal Chemistry, 2006